🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.980
+0.070 (2.41%)
Nov 18, 2026, 4:00 PM EST - Market closed

Galectin Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3012688110367123
Market Cap Growth
-15.37%231.27%-21.14%52.89%-45.33%-3.92%
Enterprise Value
32838516314784109
Last Close Price
2.984.161.291.661.132.07

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
--2.12-0.79-1.70-2.0946.96
P/TBV Ratio
-----335.62

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.16-1.09-1.03-1.21-1.2411.11
Net Debt / Equity Ratio
-0.81-0.95-0.89-0.78-0.66-4.05
Quick Ratio
0.252.210.431.641.434.39
Current Ratio
0.282.420.491.771.584.63
Return on Equity (ROE)
------227.74%
Return on Assets (ROA)
-71.46%-67.81%-116.08%-96.17%-75.96%-52.81%
Return on Capital Employed (ROCE)
44.30%-174.60%236.90%-304.00%-463.60%-92.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-10.96%-11.50%-58.11%-40.00%-57.74%-24.85%
Buyback Yield / Dilution
-12.88%-2.56%-3.57%-1.29%-1.48%-2.63%
SEC Filings: 10-K · 10-Q